Cross cultural adaptation of the Greek sarcopenia quality of life (SarQoL) questionnaire

References

• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in older people. Age Ageing. 2010;39:412–423.
   PubMed Web of Science ®Google Scholar
• Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55:769–774.
   PubMed Web of Science ®Google Scholar
• Tsekoura M, Gliatis J, Billis E. Sarcopenia: update of the literature. Arch Hellenic Med. 2017;34:42–48.
   Web of Science ®Google Scholar
• Beaudart C, Biver E, Reginster JY, et al. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing. 2015;44:960–966.
   PubMed Web of Science ®Google Scholar
• Rizzoli R, Reginster JY, Arnal JF, et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int. 2013;93:101–120.
   PubMed Web of Science ®Google Scholar
• Tsekoura M, Kastrinis A, Katsoulaki M, et al. Sarcopenia and its impact on Quality of life: a literature review. Switzerland: Springer?s Advances in Experimental Medicine and Biology (AEMB); 2017. p. 213–218.
   Google Scholar
• Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. Bmj. 2001;322:1297–1300.
   PubMed Web of Science ®Google Scholar
• Beaudart C, Reginster JY, Geerinck A, et al. Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia. Expert Rev Pharmacoecon Outcomes Res. 2017;17:335–341.
   PubMed Web of Science ®Google Scholar
• Beaudart C, Biver E, Reginster J-Y, et al. Validation of the SarQoL, a specific health-related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle. 2017;8:238–244.
   PubMed Web of Science ®Google Scholar
• Beaudart C, Edwards M, Moss C, et al. English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia. Age Ageing. 2017;46:271–276.
   PubMed Web of Science ®Google Scholar
• Gasparik AI, Mihai G, Beaudart C, et al. Psychometric performance of the Romanian version of the SarQoL®, a health-related quality of life questionnaire for sarcopenia. Arch Osteoporos. 2017;12:103.
   PubMed Web of Science ®Google Scholar
• Beaudart C, Biver E, Reginster J-Y, et al. Translation and validation of the Dutch SarQoL®, a quality of life questionnaire specific to sarcopenia. J Musculoskelet Neuronal Interact. 2017;8:238.
   Google Scholar
• http://www.sarqol.org
   Google Scholar
• Tsekoura M, Billis E, Matzaroglou C, et al. Investigation on the prevalence of Sarcopenia and related factors in elderly living in Achaia-Greece.World Conference on Osteoporosis Osteoarthritis and Musculoskeletal Diseases. Οsteoporosis International. 2017;28:1.
   Google Scholar
• Rolland Y, Lauwers-Cances V, Cristini C, et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am J Clin Nutr. 2009;89:1895–1900.
   PubMed Web of Science ®Google Scholar
• Bahat G, Tufan A, Tufan F, et al. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016;35:1557–1563.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.
   PubMed Web of Science ®Google Scholar
• Golafshani N. Understanding reliability and validity in qualitative research. Qualitative Report 2003;8:597–607.
   Google Scholar
• Heale R, Twycross A. Validity and reliability in quantitative studies. Evid Based Nurs. 2015;18: 66–67.
   PubMedGoogle Scholar
• Pappa E, Kontodimopoulos N, Niakas D. Validating and norming of the Greek SF-36 Health Survey. Qual Life Res. 2005;14:1433–1438.
   PubMed Web of Science ®Google Scholar
• Yfantopoulos J. The Greek Version of the EuroQol (EQ-5D) Instrument. Arch Hellenic Med. 2001;18:180–191.
   Google Scholar
• Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–343.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age and Ageing. 2014;43:748.
   PubMed Web of Science ®Google Scholar
• TK, Koo MY, Li A. Guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155–163.
   PubMed Web of Science ®Google Scholar
• Munro B. Statistical methods for health care research (5th ed.). Philadelphia: Lippincott Williams and Wilkins; 2005. p. 239–259.
   Google Scholar
• Nunnally JCBI. Psychometric theory. New York: McGrawHill Inc; 1994. Available from: http://www.amazon.com/Psychometric‐Theory‐Jum‐C‐Nunnally/dp/007047849X
   Google Scholar
• Beaudart C, Reginster JY, Petermans J, et al. Quality of life and physical components linked to sarcopenia: The SarcoPhAge study. Exp Gerontol. 2015;69:103–110.
   PubMed Web of Science ®Google Scholar
• Morishita S, Kaida K, Tanaka T, et al. Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2012;20:3161–3318.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Gordon HG, Roman J. How to develop and validate a new health-related quality of life instrument. In Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd edition. B. Spilker editor. Philadelphia (PA): Lippincott-Raven Publishers; 1996. p. 49–56.
   Google Scholar
• Sarfati D. How Do We Measure Comorbidity? Springer Science + Business Media Singapore. B. Koczwara editor. Australia: Cancer and Chronic Conditions; 2016. p. 35–70.
   Google Scholar
• Barrera-Ariza L, Gonzalez- Correa CH, Gonzalez-Correa CA. Quality of reporting of bioelectrical impedance analysis (BIA) studies evaluating body fluid volumes: The need for standardization. World Congress on Medical Physics and Biomedical Engineering, IFMBE Proceedings 25/VII, Munich; 2009. p. 244–246.
   Google Scholar
• Tsekoura M, Billis E, Gliatis J, et al. Assessment of muscle mass for elderly population in clinical practice. Arch Hellenic Med. 2017;34:745–753.
   Web of Science ®Google Scholar
• Kim KM, Jang HC, Lim S. Differences among skeletal muscle mass indices derived from height-, weight-, and body mass indexadjusted models in assessing sarcopenia. Korean J Intern Med. 2016;31:643–650.
   PubMed Web of Science ®Google Scholar
• Buckinx F, Landi F, Cesari M, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle. 2018;9:269–278.
   PubMed Web of Science ®Google Scholar
• Deurenberg P, Pietrobelli A, Wang ZM, et al. Prediction of total body skeletal muscle mass from fat-free mass or intra-cellular water. Int J Body Compos Res. 2004;2:107e13.
   Google Scholar
• Gonzalez MC, Heymsfield SB. Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating? Journal of Cachexia, Sarcopenia and Muscle. 2017;8:187–189.
   PubMed Web of Science ®Google Scholar